ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, GATA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, KITLG, SFRP2, NASP, MSH2, KIT, BCL2, BCL2L1]
GO:0032693;negative regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[CD274, IL23A, PRG2, LILRB1, PDCD1LG2, FCGR2B, DLL1, JAK3]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[NRP1, NLGN1, CCL21, FMR1, ARAP1, CCR7]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, SLA2, FGF5, IMPA2, PDGFRB, PDGFRA, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, PDGFA, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, CD28]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[FASLG, TNF, CASP8AP2, SORT1, DAPK1, TNFRSF10B, BCL2]
GO:0032848;negative regulation of cellular pH reduction;12.0;0.9326813400603323;0.9144609826203107;9.589303539338841;367.95635365503233;9.777073627680469;0.012315168017615022;0.9481203125901445;[BCL2]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, CD38, EDN1, AVPR1A, SFRP2, MAP1B, S100A8, HBEGF, TAF9, PAK1, SFN, TGFB2, SYT2, FN1, CXCL12, BCL2]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, HNF4A, TNR, SEMA6A, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, PAK1, FRZB, SPP1, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, PML, BCL6, BCL2, SIPA1]
GO:0006958;complement activation, classical pathway;8.0;1.0;0.875;9.628524252492122;171.02669507306572;4.7081694254602375;0.005724109570062889;0.6157760033703056;[, C1QB, IGHM, C1QA, CR2, CR1, CLU, C2, IGHG1, IGKC, IGLV1-44, TRBC1, IGHD, SERPING1, IGHA1, IGKV3-20, C1QC]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[NRP1, STMN1, EPHB2, EPHB1, DCC, PAX2, MAP1B, CDH11, DSCAML1, SLITRK6, LINGO1, GP5, POU4F1, PTK2, NR4A2, LRFN4, OGN, BCL2]
GO:2000510;positive regulation of dendritic cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;509.141903474748;7.697632086000634;0.01704052131133542;0.8088982747154926;[CCL21, CCR7, CCR6]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, SESN3, KCNH1, KCNH2, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, TNFRSF1B, LCP2, LCP1, DTL, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, RIN2, EPHA2, RACGAP1, CD14, PAG1, CCR1, PTK2, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, IL18, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, HBEGF, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, CSF1R, CALCRL, CUL5, ITPR3, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, BCL2, CSPG4, LAT, BCL2L1, TREM1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[NAE1, CIT, BCL2, BCL2L1]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, IL6, BCL2, CAMK1]
GO:0007260;tyrosine phosphorylation of STAT protein;10.0;1.0;0.9152410118609203;9.628524252492122;339.94073760219794;7.57984905034425;0.011377510560744174;0.8028748447945538;[LIF, JAK3]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, IHH, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, POF1B, CDH1, MED1, MEF2C, ACTN1, COL23A1, CLDN3, ADAM8, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, BCL6, ID1, NOX4, IL7R, NRP1, COL14A1, ITGB3, LAMC1, ITGB7, ITGA4, STRADB, GP1BA, GREM1, PALLD, COL6A2, CDH11, COL6A1, COL6A3, CDH17, YAP1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[PRKCD, PML, MELK, BCL2, CYP1B1]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, SFN, MLH1, TNFRSF1B, SIRT1, PML, MSH6, MSH2, BCL3, BCL2, EPHA2, BCL2L1]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, KLF4, MAPK13, COL1A1, FABP1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0042149;cellular response to glucose starvation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;115.90251486529202;6.063501560976162;0.003879152867050031;0.6610071170671804;[SESN3, UPP1, BCL2, SIK1]
GO:0002885;positive regulation of hypersensitivity;10.0;0.7980440201809971;0.8142630219514189;9.439282252853593;636.6186907884354;8.16763571524637;0.021307054661064313;0.8329342821725234;[FCER1G, BTK, CCR7]
GO:2000525;positive regulation of T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;265.86994678880865;9.083926447120524;0.008898427851603871;0.8607930461318132;[CCR7]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, THY1, EPB41L5, CCR7, CD36, JUP, CCL21, CEACAM6, NINJ1, TEK]
GO:0002922;positive regulation of humoral immune response;6.0;0.6997970393407541;0.6730188322605215;9.0306872517365;108.8065326900253;7.069023426578259;0.0036416567296131998;0.6846304993685643;[FCER2, LTA, CCR7, FCGR2B, TNF]
GO:2000526;positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation;9.0;1.0;0.896240625180289;9.628524252492122;733.9494972534095;9.777073627680469;0.024564629161408138;0.896240625180289;[CCR7]
GO:0001836;release of cytochrome c from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;6.686031174322154;7.408380313817617E-4;0.665044257777226;[JUN, BCL2A1, IFI6, BCL2, SFN, CLU, BCL2L1]
GO:0002408;myeloid dendritic cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;125.05555036753341;8.67846133901236;0.004185496728112903;0.8188169164668168;[CCR7, CCL19]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, CD38, NCKAP1L, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, BCL2, CARD11, CD320]
GO:0031069;hair follicle morphogenesis;4.0;1.0;0.75;9.628524252492122;21.56700107071243;6.518977089658987;7.21828116795923E-4;0.5833807915285978;[TGFB2, IGFBP5, BCL2]
GO:2000522;positive regulation of immunological synapse formation;8.0;1.0;0.875;9.628524252492122;159.40900365360346;9.777073627680469;0.005335275893496953;0.875;[CCR7]
GO:0072610;interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[CCR7, CCL19]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0031103;axon regeneration;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;96.50678923292918;6.832634648514029;0.00322999538515464;0.7003406189322132;[JUN, CHL1, TNC, CTNNA1, BCL2, JAM3]
GO:0035265;organ growth;3.0;0.7671156992804218;0.5816781622303554;8.753055515138222;22.582921643529833;6.444869117505266;7.558300640989654E-4;0.5277112189764278;[PDGFRB, PSAP, BCL2, DLL1]
GO:0034695;response to prostaglandin E;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;134.30653146733928;6.599019797332524;0.004495118740180942;0.6883935445785896;[CCL21, PTGER2, PRKCE, TGFBR3, P2RY6, AKT1, CCR7, CCL19, PTGDR]
GO:0033089;positive regulation of T cell differentiation in thymus;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;998.0942985465404;7.292166977892469;0.03340531794580182;0.7881627702307852;[EGR3, VNN1, IL1B, IHH, ADAM8, IL7R]
GO:0014042;positive regulation of neuron maturation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;592.6446807852996;8.390779266560578;0.019835284120298998;0.8253454670833372;[BCL2]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, GATA1, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, RARA, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, IL23A, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR2, IL10, EDN1, SYK, RHOG, IL18, PDCD1LG2, AVPR1A, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, IL6R, PDGFRB, GHSR, PDGFRA, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, LTBR]
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;7.0;1.0;0.8509193652572005;9.628524252492122;76.30875120206336;6.375876246018314;0.0025539852293156346;0.6769819729871445;[BCL2A1, DCC, IL1A, IL1B, BCL2, BCL2L1]
GO:0040018;positive regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.45792876686207;6.280566066213989;0.004868345972189967;0.6443087532925187;[GHSR, GHR, VIL1, GH1, BCL2, PLS1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, GATA3, CCNB2, HOXA3, BCL11B, BCL2, MAD1L1]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, PDGFA, CSF2RB, IQGAP3, CSF2RA, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, STRADB, IL18, GFRA3, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0002731;negative regulation of dendritic cell cytokine production;8.0;0.8933024483968273;0.8216512241984136;9.54514264355307;385.9057217908713;9.083926447120524;0.012915917215738997;0.839552420951524;[JAK3]
GO:2000811;negative regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.9210822679579;6.943860283624253;0.0034781451006065307;0.7301093378270707;[CAV1, PTK2, CEACAM6, CEACAM5, BCL2, SNAI2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, IFNGR1, GPR35, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL1, BIRC5, LCP1, BIRC3, CX3CR1, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, IFIT3, IFIT2, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, IL18, GP1BA, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, CD74, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, LTB, CAMK2D, SAMHD1, NCAM1, MX2, CD4, LTBR]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, IL6, BCL2, ALPL, SDC1, FOSB]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, BTG2, SOX4, TFDP1, PCNA, CCNB1, GPNMB, NACC2, E2F1, CCL2, SFN, E2F7, PLK2, KLF4, PML, CNOT3, CDK1, BCL2, EZH2]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, GATA3, THY1, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, CTLA4, CD38, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, BCL2, PTPN6, MNDA]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[HP, BRCA1, SLC30A10, CD34, IL10, CAV1, PAX2, BCL2]
GO:0035771;interleukin-4-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.390779266560578;0.00101047745553359;0.7800242071602487;[IL2RG, JAK3]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, STRADB, IFI6, TNF, GATA1, IL1A, IL1B, CTNNA1, BCL2, AKT1, SNAI2, FYN, PF4, BCL2L1]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD28, PTPN6, CD24, CARD11]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[BCL11B, FZD5, FZD8, DNAJA3, BCL2, CCR6]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[HERC5, SKP2, FBXW2, CDC34, BARD1, HACE1, UBE2C, MARCH1, BCL2, TNFAIP3, BRCA1, RNF144B, DTL, RNF24]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, SLA2, GRAP2, FYN, CSK, JAK3, LYN, SYK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0043375;CD8-positive, alpha-beta T cell lineage commitment;6.0;1.0;0.8231203125901445;9.628524252492122;44.46807846579176;9.777073627680469;0.0014883065675776633;0.8231203125901445;[BCL2]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, EDN1, VCAM1, SLC7A11, TNF, NFKB1, CNR1, BCL2, HMOX1]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, BCL2, NCKAP1L, PKN1]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[CEBPB, INHBA, FANCG, ADCYAP1, KIT, CTNNA1, BCL2, MMP19, BCL2L1]
GO:0001662;behavioral fear response;5.0;1.0;0.7902410118609202;9.628524252492122;37.889479621082295;6.375876246018314;0.0012681267845998157;0.6163036195908642;[GABRA5, DPP4, ADCYAP1, BCL2, DRD4]
GO:0050862;positive regulation of T cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.212124270218933;0.01221922354838398;0.7438283705770736;[TRAT1, LCK, CCR7]
GO:2000547;regulation of dendritic cell dendrite assembly;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;51.76168527241457;8.67846133901236;0.001732417023575362;0.8188169164668168;[CCL21, CCR7, CCL19]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, CCL21, LILRB1, CCR7, CCL19]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[PAX2, HOXA11, GREM1, BMP2, BCL2]
GO:0010523;negative regulation of calcium ion transport into cytosol;9.0;0.8259837884571596;0.8092325194088689;9.417215158824915;155.07739949607335;6.943860283624253;0.00519030100053507;0.7513499630073597;[TGFB1, FKBP1B, BCL2]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, ADAM8, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, CEACAM5, KIT, PECAM1, XCL1, CEACAM8, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, SPARC, CD80, SERPINE1, CXCL13, MPO, LOXL1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, TLR4, CX3CR1, CEBPB, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.12593595584649;6.343086423195323;0.002815619368015229;0.6753050999230941;[PPP1R15A, CEBPB, TNFRSF10B, PML, BCL2]
GO:0038114;interleukin-21-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.697632086000634;0.00101047745553359;0.7445766281117727;[STAT4, IL2RG, JAK3]
GO:0038113;interleukin-9-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.16763571524637;0.00101047745553359;0.7686126355688037;[IL2RG, JAK3]
GO:0038116;chemokine (C-C motif) ligand 21 signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;32.49393932031223;9.777073627680469;0.0010875429064040555;0.875;[CCR7]
GO:0038115;chemokine (C-C motif) ligand 19 signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;32.49393932031223;9.777073627680469;0.0010875429064040555;0.875;[CCR7]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RB, IL2RG, JAK3]
GO:1904894;positive regulation of STAT cascade;8.0;0.8653626801206646;0.8076813400603323;9.517298617381897;238.82315740091596;5.433268205826786;0.007993196151321231;0.6528575887187926;[CSF1R, CD40, IFNA2, PRL, GHR, CCL5, CYP1B1, FYN, IL6R, LYN, F2R, LIF, IL18, PARP9, GH1, IL6, IFNG, IL23A, KIT, IL7R]
GO:0038111;interleukin-7-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;6.832634648514029;0.00101047745553359;0.7003406189322132;[IL2RG, SOCS2, IL7R, JAK3]
GO:0006882;cellular zinc ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;329.3407122754199;6.375876246018314;0.011022737252460356;0.7413036195908642;[ATP7B, LCK]
GO:0000018;regulation of DNA recombination;7.0;0.6056485694559711;0.6537436499851861;8.388833365564107;73.34977914704017;5.395046993006588;0.0024549510975359675;0.6268223193749;[CD40, TFRC, CHEK1, IL10, MSH6, MSH2, BLM, UNG, FIGNL1, TGFB1, TNFSF13, MLH1, RAD50, RAD51, BCL6, CD28, IL7R]
GO:0002320;lymphoid progenitor cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.223059144383958;22.164838071467113;7.379178354882098;7.418371831928127E-4;0.6676125360964777;[SPI1, KIT, BCL2, GATA3, SOX4]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, CACNA1F, CORO1A, CCNB2, SIT1, BCL2, NCKAP1L, JAK3]
GO:0050871;positive regulation of B cell activation;8.0;0.7436939687323844;0.7468469843661922;9.117698628726131;160.32529438548238;4.695669262696007;0.00536594331968482;0.6151367444652258;[, IGHM, CDKN1A, CD40, TFRC, TNFSF13B, IGHG1, TRBC1, CD38, MEF2C, SYK, FCRL3, ATP11C, MIF, MSH6, MSH2, BTK, IGHD, CARD11, NOD2, UNG, IGKC, INPP5D, NCKAP1L, IGHA1, CD74, TGFB1, TNFSF13, MLH1, BST1, IL6, PTPRC, BCL6, CD28, BCL2, CD320]
GO:0001865;NK T cell differentiation;8.0;1.0;0.875;9.628524252492122;92.19446145895849;8.67846133901236;0.0030856656554028718;0.8188169164668168;[ITK, BMX]
GO:0070244;negative regulation of thymocyte apoptotic process;11.0;1.0;0.9324289523296623;9.628524252492122;182.70429597134583;7.697632086000634;0.006114948362969828;0.8260862151842345;[BLM, JAK3]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, UNC93B1, SAMHD1, MX2, CARD9, LILRB1, PML]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, F3, IFI27, LCK, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[CCL21, PRKCE, F2R, FASLG, ITPR3, JPH2, PTPRC, LCK, FKBP1B, XCL1, CCR7, CCL19, CCR5]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, PHB2, SLC8A1, AQP1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, E2F1, HMOX1, FABP1, BCL2]
GO:0071731;response to nitric oxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;66.42530163189308;6.832634648514029;0.0022231950667291668;0.639662265535933;[FOXO1, DNM2, AQP1, CCNA2, CCR7, CCL19]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ACTN1, PTPRK, SORBS1, THY1, ARHGAP6, DLC1, BCL2]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[LRRK2, CLU, AKT1, PLAUR, MIF, MMP9, SIRT1, SFRP2, NDUFS3, BCL2A1, TAF9, PTGS2, FIGNL1, CD74, WFS1, VNN1, CXCL12, BCL2, SNAI2, GRINA, BCL2L1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, CETN3, CALML4, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, EDN1, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CAMK2D, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, LAT]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[PLEKHF1, NACC2, CAV1, SIRT1, LCK, BCL2, ATF3, S100A8, NOX1, BCL2L1]
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway;8.0;1.0;0.875;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.7438283705770736;[LYN, GHR, GH1, PRL, JAK3]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, LYL1, HHEX, LGALS1, BLNK, JAK3, TPD52, IL10, CR2, IFNA14, ITGA4, IFNA16, NFAM1, ATP11C, MSH2, KIT, CDH17, CARD11, IFNA10, DLL1, CD79B, CD79A, NKX2-3, IFNA21, VCAM1, KLF6, CD40LG, BCL6, BCL3, FCGR2B, ITM2A]
GO:0031274;positive regulation of pseudopodium assembly;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;200.71212349518538;7.212124270218933;0.006717654144200148;0.7650689957573628;[CCL21, KIT, CCR7]
GO:0014031;mesenchymal cell development;4.0;0.8653626801206646;0.6826813400603323;9.474373572664863;32.15320660831846;6.409777797693995;0.001076138889173156;0.5777963346592216;[EDN1, JAG1, EDNRA, BCL2, SNAI2]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;990.0589542238915;6.599019797332524;0.033136382202663156;0.7527151911823093;[TFDP1, TP53BP2, E2F1, BCL2, SFN, YWHAH]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, BCL2, IL7R, MS4A1, CARD11, IFNA21, IFNA10]
GO:0046425;regulation of JAK-STAT cascade;8.0;0.7586651285174919;0.754332564258746;9.158520623246385;46.16872612457469;4.77312732173501;0.0015452257142336023;0.6190979532066485;[IFNA5, IFNA4, IFNA7, CD40, IFNA2, LRRC4, PRL, IFNA8, GHR, PPP2R1A, LRRTM4, CYP1B1, IL6R, JAK3, IFNA14, IFNA16, F2R, BGN, IL18, GP1BA, PARP9, DCN, IFNG, HGS, IL23A, KIT, IFNA10, CSF1R, LRRC19, SOCS2, FLRT2, CCL5, FYN, IFNA21, LYN, EGF, CAV1, LIF, PODN, GH1, IL6, BCL3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, IL18, PDCD1LG2, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CD1D, CORO1A, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, CLEC4D, SLPI, IL23A, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, CD4]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, CD3G, PTPN22, CD3E, CD3D, CCR9, CCR6, SOX4, ANXA1, FCER1G, RSAD2, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, KIT, BLM, GATA3, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, FZD8, BMX, CD4, PTPRC, DNAJA3, BCL3, CD28, BCL2, IL7R, GPR18, IL18R1]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, CHUK, TNFRSF1B, LTA, LTB, BIRC3, TNFRSF11A, TNFRSF17, TNFSF14, TNFSF12, TNFSF13, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, LTBR]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[ALAS2, SPI1, GATA3, GATA1, AHSP, JAK3, LYN, INHBA, KLF1, TGFBR3, KIT, ACIN1, TRIM10]
GO:0045221;negative regulation of FasL biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;967.9208223894049;9.777073627680469;0.032395438853188026;0.896240625180289;[JAK3]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, IL1RN, CCNH, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, FPR1, TGFA, PDGFA, IQGAP3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, EGR1, ACE, FZD5, FZD8, CDC6, AZU1, PTK2, NOX4, CD24, EZH2, CDKN1A, CD40, CCR7, MAP4K1, EDN1, SYK, STRADB, IL18, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, TNF, CLU, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, CCNB1, STAP1, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, CYR61, GHR, GRM5, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, MAPK14, CD4]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[BLM, SLC46A2, CCL5, PRKCQ, IL7R, JAK3]
GO:0010507;negative regulation of autophagy;7.0;0.7436939687323844;0.7227663496233927;9.117698628726131;217.48068666745357;5.500407508664414;0.007278882862848883;0.6322104610454062;[LRRK2, PTPN22, AKT1, TSC2, HMOX1, SNCA, PTK2, BCL2]
GO:0046671;negative regulation of retinal cell programmed cell death;7.0;0.9326813400603323;0.8172600352873667;9.584072489921288;304.76275982415854;9.777073627680469;0.010200135302637775;0.8509193652572005;[BCL2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, CD74, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ACTG2, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, YWHAH, MYOCD, DDX58, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, RBM38, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, RARA, ENG, NR1I2, EPCAM, GSN, NR1H2, GTF2H1, POU4F1, PLP1, FOSB, PF4, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DAB2, COPS5, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPB, SMARCD3, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CD74, CCL21, SLC11A1, CCR7, CCL19, NOD2]
GO:0001915;negative regulation of T cell mediated cytotoxicity;9.0;0.8933024483968273;0.8428918493787028;9.557065288509976;365.562885098783;7.9853141584524145;0.012235060779019208;0.8046099625986299;[CEACAM1, PTPRC, LILRB1, FCGR2B, IL7R]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IL10, EDN1, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCE, PRKCD, VRK1, PRKCQ, CCNB1, PLK2, PLK1, CLK1, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, SGK1, CAMK2D, AURKB, MAPK14, MAPK13, CAMK4, PKN1, CAMK1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCD, CAD, VRK1, CAMK2D, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, SERPINE1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, IGFBP3, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, THY1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, ENG, CX3CR1, LRP1, THBS1, CCL2, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0033689;negative regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.18040277096193;7.57984905034425;0.0021145912220731796;0.710754145523778;[GREM1, BCL2]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, NTF3, CCR7, ECT2, EVI5, CCL21, RHOG, TBC1D9, TBCK, EPHA2]
GO:0006582;melanin metabolic process;5.0;0.811012628672052;0.6957473261969462;9.318369324188282;72.72537912965618;7.212124270218933;0.002434052990877658;0.659069382437994;[TRPC1, BCL2]
GO:0008361;regulation of cell size;5.0;0.7763722522362496;0.6784271379790451;8.999915593069748;28.02071028012121;5.54296712308321;9.378279560736312E-4;0.5737086083097278;[IQGAP3, AQP1, AKT1, SLC12A2, EDN1, SLC12A1, VAV1, XK, IL7R, SHANK3]
GO:0045626;negative regulation of T-helper 1 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2656.54802066489;8.67846133901236;0.08891227151365512;0.9063718812344532;[JAK3]
GO:0097022;lymphocyte migration into lymph node;8.0;1.0;0.875;9.628524252492122;30.235634434558513;9.777073627680469;0.001011959474220325;0.875;[CCR7]
GO:0010559;regulation of glycoprotein biosynthetic process;7.0;0.6634067003016617;0.6826227154080313;8.902587249109185;149.75732045160512;6.139487467954083;0.00501224274267701;0.6648930398837374;[CCL21, PAWR, GATA1, BCL2, CCR7, CCL19, ITM2A, RAMP1, JAK3, HBEGF, ITM2C]
GO:0097029;mature conventional dendritic cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;70.62522642078902;8.390779266560578;0.002363762769726602;0.7522251544931926;[PRTN3, CCR7, CCL19]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, DOCK4, POSTN, IGFBP5, P2RY6, PAK1, NR4A3, CCL5, PDGFD, BCL2, NOX4]
GO:0051902;negative regulation of mitochondrial depolarization;8.0;1.0;0.875;9.628524252492122;107.5075323722012;7.8311634786251565;0.003598180358000013;0.7754860644832351;[IFI6, BCL2]
GO:0032469;endoplasmic reticulum calcium ion homeostasis;10.0;0.8259837884571596;0.8282329060895002;9.52844079393514;288.6919123283276;6.686031174322154;0.009662258499776054;0.7571649570480019;[CAMK2D, WFS1, PML, BCL2, GRINA]
GO:0033033;negative regulation of myeloid cell apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.360260265897443;105.01969455662797;7.069023426578259;0.003514914665221449;0.7365101867784198;[GHSR, FCER1G, CCL5, CXCR2, CLEC5A, IRF7, BCL2, MIF, NOD2, CCR5]
GO:0050706;regulation of interleukin-1 beta secretion;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;155.12756668048587;6.166155715036245;0.005191980051049822;0.7305785018834392;[ORM1, NOD2, PYCARD, NLRP3, CCR7, CCL19, FZD5, PML, NLRP12, TLR8, TLR4]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP2R1A, CDC25A, PTPRE, PTPRC, BCL2, PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, PPP1R12A, DUSP1, DUSP6, LCK, PPP1R15A, TPTE, PPP1CA, PTPN6]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, TGFA, PDGFA, SLC30A10, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, VAV1, HCK, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, TSC2, PDGFRL, COL4A2, KIF16B, COL4A1, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, C5AR1, AVPR1A, SELE, RASGRP4, EDNRA, PLCG1]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[IL1RN, ADM, PRL, THBD, CD38, TGFB1, IGFBP5, CAD, FOS, ADCYAP1, CLDN4, PNOC, RARA, BCL2, FOSB]
GO:0022898;regulation of transmembrane transporter activity;6.0;0.5295311121456219;0.5878858686629554;7.417506353023566;24.765424706708153;4.321752512322768;8.288764774983087E-4;0.5441349370523758;[, FMR1, EPHB2, MEF2C, DAPK1, PRKCE, ACTN4, ATP1B2, ATP1B1, GEM, CFTR, KCNE3, TWIST1, ADRB2, DRD4, CAV1, EHD3, BCL2, FXYD6, CTSS, GRM5, JPH2, PDE4B, YWHAH, GPR35, MMP9, DNM2, SHANK3, NLGN1, CAMK2D, PTAFR, PLN, DMD, FKBP1B, GOPC]
GO:0048743;positive regulation of skeletal muscle fiber development;9.0;1.0;0.896240625180289;9.628524252492122;623.8299612915386;7.697632086000634;0.02087902739391249;0.7898978880348613;[BCL2]
GO:0007167;enzyme linked receptor protein signaling pathway;6.0;0.5334320500414464;0.5898363376108677;7.041834908394179;26.50247477320489;3.253511321530957;8.87013979980389E-4;0.48950503287698693;[CYFIP1, SLA2, F11R, EPS8, STMN1, AKT1, EPHB2, EPHB1, RUNX2, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, TGFA, PDGFA, SLC30A10, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, EGR1, JUN, LIF, GP6, PTK2, COL1A1, COL1A2, ID1, NRP1, ITK, PTPRR, NRP2, PTPRK, CD3E, JAK3, SYK, GAB1, FOS, SIRT1, VAV1, RGMA, HCK, KIT, HBEGF, ENG, GUCY2C, FSTL1, PAK1, NTF3, SORT1, USP9Y, SORBS1, SULF1, SULF2, COL3A1, ZYX, NCF4, CTGF, FGF5, CDH5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, TSC2, PDGFRL, COL4A2, KIF16B, COL4A1, ADAM9, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB2, TGFB1, CAV2, CRIM1, INHBA, BMX, VIL1, GH1, BMP2, NR4A3, FES, CSPG4, ITGB5, ITGB3, GHR, TMEM100, BLNK, MMP2, MMP9, TGFBR3, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, PML, CD4, CD7, TEK]
GO:0045636;positive regulation of melanocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;190.69673191605972;8.390779266560578;0.006382448001314043;0.7800242071602487;[BCL2, ADAMTS20]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB, KIT, BCL2]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, MAPK14, CD40LG, IFNG, IL23A, LTB, TLR4, TLR2]
GO:0045084;positive regulation of interleukin-12 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;8.16763571524637;0.027942676825076673;0.7926932703116032;[LTB, TLR4]
GO:0048599;oocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;7.292166977892469;0.0024359751381706407;0.6631627702307852;[BCL2]
GO:0048753;pigment granule organization;5.0;0.8436909121759173;0.712086467948879;9.223059144383958;20.915744831851537;6.518977089658987;7.000311565738116E-4;0.623621803389518;[RAB32, BCL2]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[F2R, FLT3LG, CORO1A, GATA1, BCL2, CCR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFD, GATA3, CD1D, LY9, C2, KLRK1, SLAMF7, S100A12, CD14, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, C1QC, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, TYROBP, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, PML, CD6, PTX3, PTPN6, CD244]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[IL1RN, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, EDN1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, NOD2, PAK1, CCL19, FZD5, CCL21, CARD9, FZD8, CD40LG, PKN1, LTBR, FCGR2B, NOX1]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, LMOD1, PYCARD, CCR7, PRKCE, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, VIL1, JMY]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0035723;interleukin-15-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.212124270218933;0.00101047745553359;0.7197477358342742;[IL2RG, CD4, IL2RB, JAK3]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, IFIT1, IFIT3, IFIT2, TCL1A, AKT1, TNFSF11, TRIM25, DAPK1, CDC34, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CD40, BRCA1, CCR7, HLA-DPA1, EDN1, MME, ARG1, SIRT1, TLR4, TLR2, CCL13, CXCR4, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, POU4F1, NLRP12, ZYX, IL18R1, IL17A, PYCARD, TLE4, POSTN, PCOLCE, KMO, KIF16B, CSF1R, CALCA, CSF2RB, CORO1A, VCAM1, NFKB1, BSPRY, ALAD, CHUK, ITGA4, IL3RA, CHI3L1, XCL1, MCM2, CEBPB, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, MAPK14, KLF4, PML, MAPK13, CD4, KLF5, IMPDH2, PTPN6, RBMX]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, LILRB1, IRAK3, THBS1, NFKB1, TLR8, JAK3]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[CALCA, ECM1, TWIST1, TNF, GATA1, HOXA2, MEN1, CCR1, MEF2C, TGFB1, IGFBP5, TMEM64, AXIN2, GREM1, ID1, BCL2]
